Tesamorelin (6mg), CJC-1295 No DAC (3mg), Ipamorelin (3mg) (Blend)

The Tesamorelin (6 mg) + CJC-1295 (No DAC) (3 mg) + Ipamorelin (3 mg) formulation, a 12 mg total blend is designed for research use only to investigate potential synergistic effects on growth hormone–releasing hormone (GHRH) stimulation. This combination is studied for its collective influence on metabolic function, fat oxidation, cellular repair, and endocrine regulation through the coordinated activation of GHRH and GHRP pathways.

This peptide blend is intended exclusively for laboratory research purposes and is not for human or veterinary use.